Long-term ethanol consumption initiates atherosclerosis in rat aorta through inflammatory stress and endothelial dysfunction

Vascular Pharmacology

Volumn 57, Issue 2-4, 2012, Pages 72-77

  Shirpoor, Alireza ^a   Salami, Siamak ^b   Khadem Ansari, Mohammad Hassan ^a   Heshmatian, Behnam ^a   Ilkhanizadeh, Behrouz ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Blood pressure; Cell adhesion molecules; Ethanol; Foam cell

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FOAM CELL; HEMODYNAMICS; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE RATE; RAT; RIGIDITY; SHAM PROCEDURE; STRESS; SYSTOLIC BLOOD PRESSURE;

ALCOHOL DRINKING; ANIMALS; AORTA; ATHEROSCLEROSIS; BLOOD PRESSURE; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; ETHANOL; FOAM CELLS; INFLAMMATION; MALE; RATS; RATS, WISTAR;

EID: 84865421408     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.04.001     Document Type: Article

References (55)

1. Alastruey J., Nagel S.R., Nier B.A., Hunt A.A., Weinberg P.D., Peiro J. Modelling pulse wave propagation in the rabbit systemic circulation to assess the effects of altered nitric oxide synthesis. J. Biomech. 2009, 42:2116-2123.
2. Avellone G., Di Garbo V., Campisi D., De Simone R., Raneli G., Scaglione R., Licata G. Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. Eur. J. Clin. Nutr. 2006, 60:41-47.
3. Balakrishnan R., Allender S., Scarborough P., Webster P., Rayner M. The burden of alcohol-related ill health in the United Kingdom. J. Public Health (Oxf.) 2009, 31:366-373.
4. Bau P.F., Bau C.H., Rosito G.A., Manfroi W.C., Fuchs F.D. Alcohol consumption, cardiovascular health, and endothelial function markers. Alcohol 2007, 41:479-488.
5. Baumberg B. The global economic burden of alcohol: a review and some suggestions. Drug Alcohol Rev. 2006, 25:537-551.
6. Bevilacqua M.P., Stengelin S., Gimbrone M.A., Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989, 243:1160-1165.
7. Brinton E.A. Effects of ethanol intake on lipoproteins and atherosclerosis. Curr. Opin. Lipidol. 2010, 21:346-351.
8. Callow A.D. Endothelial dysfunction in atherosclerosis. Vascul. Pharmacol. 2002, 38:257-258.
9. Chatterjee A., Catravas J.D. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul. Pharmacol. 2008, 49:134-140.
10. Chaves A.A., Joshi M.S., Coyle C.M., Brady J.E., Dech S.J., Schanbacher B.L., Baliga R., Basuray A., Bauer J.A. Vasoprotective endothelial effects of a standardized grape product in humans. Vascul. Pharmacol. 2009, 50:20-26.
11. Clausell N., Prado K.F., Ribeiro J.P. Increased plasma levels of soluble vascular cellular adhesion molecule-1 in patients with chest pain and angiographically normal coronary arteries. Int. J. Cardiol. 1999, 68:275-280.
12. Costacou T., Lopes-Virella M.F., Zgibor J.C., Virella G., Otvos J., Walsh M., Orchard T.J. Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. J. Diabetes Complications 2005, 19:183-193.
13. Costanzo S., Di Castelnuovo A., Donati M.B., Iacoviello L., de Gaetano G. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J. Am. Coll. Cardiol. 2010, 55:1339-1347.
14. Costanzo S., Di Castelnuovo A., Donati M.B., Iacoviello L., de Gaetano G. Cardiovascular and overall mortality risk in relation to alcohol consumption in patients with cardiovascular disease. Circulation 2010, 121:1951-1959.
15. Cybulsky M.I., Won D., Haidari M. Leukocyte recruitment to atherosclerotic lesions. Can. J. Cardiol. 2004, 20(Suppl. B):24B-28B.
16. da Luz P.L., Coimbra S.R. Wine, alcohol and atherosclerosis: clinical evidences and mechanisms. Braz. J. Med. Biol. Res. 2004, 37:1275-1295.
17. Di Minno M.N., Franchini M., Russolillo A., Lupoli R., Iervolino S., Di Minno G. Alcohol dosing and the heart: updating clinical evidence. Semin. Thromb. Hemost. 2011, 37:875-884.
18. Estruch R., Sacanella E., Mota F., Chiva-Blanch G., Antunez E., Casals E., Deulofeu R., Rotilio D., Andres-Lacueva C., Lamuela-Raventos R.M., de Gaetano G., Urbano-Marquez A. Moderate consumption of red wine, but not gin, decreases erythrocyte superoxide dismutase activity: a randomised cross-over trial. Nutr. Metab. Cardiovasc. Dis. 2011, 21:46-53.
19. Ferrari A.U., Daffonchio A., Albergati F., Bertoli P., Mancia G. Intra-arterial pressure alterations during tail-cuff blood pressure measurements in normotensive and hypertensive rats. J. Hypertens. 1990, 8:909-911.
20. Fries J.W., Williams A.J., Atkins R.C., Newman W., Lipscomb M.F., Collins T. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am. J. Pathol. 1993, 143:725-737.
21. Fritz M., Rinaldi G. Blood pressure measurement with the tail-cuff method in Wistar and spontaneously hypertensive rats: influence of adrenergic- and nitric oxide-mediated vasomotion. J. Pharmacol. Toxicol. Methods 2008, 58:215-221.
22. Fuchs F.D. Vascular effects of alcoholic beverages: is it only alcohol that matters?. Hypertension 2005, 45:851-852.
23. Fuchs F.D., Chambless L.E., Whelton P.K., Nieto F.J., Heiss G. Alcohol consumption and the incidence of hypertension: the Atherosclerosis Risk in Communities Study. Hypertension 2001, 37:1242-1250.
24. Ghosh S., Zhao B., Bie J., Song J. Macrophage cholesteryl ester mobilization and atherosclerosis. Vascul. Pharmacol. 2010, 52:1-10.
25. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
26. Hulthe J., Wikstrand J., Mattsson-Hulten L., Fagerberg B. Circulating ICAM-1 (intercellular cell-adhesion molecule 1) is associated with early stages of atherosclerosis development and with inflammatory cytokines in healthy 58-year-old men: the Atherosclerosis and Insulin Resistance (AIR) study. Clin. Sci. (Lond.) 2002, 103:123-129.
27. Husain K., Ferder L., Ansari R.A., Lalla J. Chronic ethanol ingestion induces aortic inflammation/oxidative endothelial injury and hypertension in rats. Hum. Exp. Toxicol. 2011, 30:930-939.
28. Ibrahim J., Berk B.C., Hughes A.D. Comparison of simultaneous measurements of blood pressure by tail-cuff and carotid arterial methods in conscious spontaneously hypertensive and Wistar-Kyoto rats. Clin. Exp. Hypertens. 2006, 28:57-72.
29. Jessup W., Wilson P., Gaus K., Kritharides L. Oxidized lipoproteins and macrophages. Vascul. Pharmacol. 2002, 38:239-248.
30. Kauhanen J., Kaplan G.A., Goldberg D.E., Salonen R., Salonen J.T. Pattern of alcohol drinking and progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1999, 19:3001-3006.
31. Kitagawa K., Matsumoto M., Sasaki T., Hashimoto H., Kuwabara K., Ohtsuki T., Hori M. Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice. Atherosclerosis 2002, 160:305-310.
32. Kloner R.A., Rezkalla S.H. To drink or not to drink? That is the question. Circulation 2007, 116:1306-1317.
33. Kohsaka S., Jin Z., Rundek T., Homma S., Sacco R.L., Di Tullio M.R. Alcohol consumption and atherosclerotic burden in the proximal thoracic aorta. Atherosclerosis 2011, 219:794-798.
34. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
35. Liuzzo G. Atherosclerosis: an inflammatory disease. Rays 2001, 26:221-230.
36. Nava E., Noll G., Luscher T.F. Nitric oxide in cardiovascular diseases. Ann. Med. 1995, 27:343-351.
37. Pasceri V., Cheng J.S., Willerson J.T., Yeh E.T. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001, 103:2531-2534.
38. Poston R.N., Haskard D.O., Coucher J.R., Gall N.P., Johnson-Tidey R.R. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 1992, 140:665-673.
39. Rehm J., Monteiro M. Alcohol consumption and burden of disease in the Americas: implications for alcohol policy. Rev. Panam. Salud Publica 2005, 18:241-248.
40. Rehm J., Taylor B., Roerecke M., Patra J. Alcohol consumption and alcohol-attributable burden of disease in Switzerland, 2002. Int. J. Public Health 2007, 52:383-392.
41. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
42. Russo G., Leopold J.A., Loscalzo J. Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis. Vascul. Pharmacol. 2002, 38:259-269.
43. Sacanella E., Vazquez-Agell M., Mena M.P., Antunez E., Fernandez-Sola J., Nicolas J.M., Lamuela-Raventos R.M., Ros E., Estruch R. Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial. Am. J. Clin. Nutr. 2007, 86:1463-1469.
44. Shaish A., Pape M., Rea T., Srivastava R.A., Latour M.A., Hopkins D., Schonfeld G. Alcohol increases plasma levels of cholesterol diet-induced atherogenic lipoproteins and aortic atherosclerosis in rabbits. Arterioscler. Thromb. Vasc. Biol. 1997, 17:1091-1097.
45. Shen M., Jia G.-L., Wang Y.-M., Ma H. Cardioprotective effect of resvaratrol pretreatment on myocardial ischemia-reperfusion induced injury in rats. Vascul. Pharmacol. 2006, 45:122-126.
46. Shirpoor A., Salami S., Khadem-Ansari M.H., Minassian S., Yegiazarian M. Protective effect of vitamin E against ethanol-induced hyperhomocysteinemia, DNA damage, and atrophy in the developing male rat brain. Alcohol. Clin. Exp. Res. 2009, 33:1181-1186.
47. Stuhlinger M.C., Tsao P.S., Her J.H., Kimoto M., Balint R.F., Cooke J.P. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 2001, 104:2569-2575.
48. Takahashi K., Takeya M., Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med. Electron Microsc. 2002, 35:179-203.
49. Taniguchi H., Momiyama Y., Fayad Z.A., Ohmori R., Ashida K., Kihara T., Hara A., Arakawa K., Kameyama A., Noya K., Nagata M., Nakamura H., Ohsuzu F. In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography. Am. Heart J. 2004, 148:137-143.
50. Vazquez-Agell M., Sacanella E., Tobias E., Monagas M., Antunez E., Zamora-Ros R., Andres-Lacueva C., Lamuela-Raventos R.M., Fernandez-Sola J., Nicolas J.M., Estruch R. Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk. J. Nutr. 2007, 137:2279-2284.
51. Wakabayashi I. Comparison of the relationships of alcohol intake with atherosclerotic risk factors in men with and without diabetes mellitus. Alcohol Alcohol. 2011, 46:301-307.
52. Wang C.H., Li S.H., Weisel R.D., Fedak P.W., Dumont A.S., Szmitko P., Li R.K., Mickle D.A., Verma S. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003, 107:1783-1790.
53. Zhong Y., Li S.H., Liu S.M., Szmitko P.E., He X.Q., Fedak P.W., Verma S. C-reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension 2006, 48:504-511.
54. Zureik M., Gariepy J., Courbon D., Dartigues J.F., Ritchie K., Tzourio C., Alperovitch A., Simon A., Ducimetiere P. Alcohol consumption and carotid artery structure in older French adults: the Three-City Study. Stroke 2004, 35:2770-2775.
55. Zwaka T.P., Hombach V., Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001, 103:1194-1197.